Abstract
Dr Blumenthal will provide the US FDA Oncology Center of Excellence perspective on Oncology Drug Approval: Challenges and Opportunity. With the recent influx of novel targeted therapies, immunotherapy and chemotherapy to treat patients with lung cancers, there are increased challenges to ensuring that safe and effective therapies are available to patients as efficiently as possible while ensuring that the evidence generated is robust and reliable. This talk will discuss FDA's perspective on global drug development. regulation, development, access
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
